Aplagon

Developer of antithrombotic compounds designed to treat complications of vascular intervention-related blood vessel occlusions. The company's compounds are engaged in developing biological mimetics of...

Healthcare

Helsinki, Finland

Founded 2009

6 employees

Website

Valuation

Share Price

N/A

Total Raised

$13.6M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Aplagon's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required